Related Experiment Video

Updated: Jun 27, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

[Aspergillosis for the pulmonologist]

S Blandin1, G David

  • 1Service de pneumologie, centre hospitalier Plateau-d'Ouilly, BP 436, 69655 Villefranche-sur-Saône cedex, France. sblandin@ch-villefranche.fr

Revue De Pneumologie Clinique
|November 21, 2008
PubMed

Insights

Aspergillus lung infections range from allergic reactions to invasive diseases, impacting individuals based on exposure and immunity. Early diagnosis and new antifungal treatments are crucial for managing these diverse Aspergillus-related respiratory conditions.

Area of Science:

  • Pulmonology
  • Mycology
  • Infectious Diseases

Context:

  • Aspergillus species are significant causes of respiratory diseases, influenced by host immunity and exposure routes.
  • Lung conditions include allergic bronchopulmonary aspergillosis, bronchial colonization, aspergilloma, and invasive aspergillosis.
  • These infections present a spectrum from hypersensitivity reactions to severe, life-threatening invasive processes.

Purpose:

  • To outline the diverse spectrum of lung diseases caused by Aspergillus.
  • To highlight diagnostic considerations for various Aspergillus-related pulmonary conditions.
  • To discuss the evolving management strategies for Aspergillus infections.

Summary:

  • Allergic bronchopulmonary aspergillosis requires consideration in severe asthma with specific clinical and serological markers.
  • Pulmonary aspergilloma and Aspergillus bronchitis represent distinct forms of Aspergillus colonization and infection.
  • Invasive aspergillosis, particularly acute and chronic forms, poses significant risks, especially in immunocompromised individuals and those with underlying lung disease.

Impact:

  • Advances in diagnostic tools like PCR and antigenemia improve early detection.
  • New antifungal therapies offer improved treatment options for Aspergillus-related lung diseases.
  • Understanding the varied clinical presentations is key to timely and effective patient management.

More Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma